Wheeler Bio Announces Grand Opening of Biomanufacturing Facility

Wheeler Bio, a contract development and manufacturing organization (CDMO) for next-gen protein therapeutics, announced today the grand opening of their state-of-the-art drug substance Current Good Manufacturing Practices (CGMP) facility inside the Ziggurat building (Echo Investment Capital) in Oklahoma City, OK.
By partnering uniquely with venture capital, Wheeler helps to ease the translational process from discovery to clinic for clients in biologics innovation. Founded by Dr. Jesse McCool, Christian Kanady of Echo, and Errik Anderson of Alloy Therapeutics and 82VS in 2021, the first-in-class CDMO was designed to provide accelerative development services to biotech startups and emerging biopharma innovators at a fair price.

Read more at Wheeler Bio


Related Posts